Skip to main content

Table 1 Basic characteristics of patients who were dispensed an OAT opioid

From: Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study

Basic characteristics

2013

2014

2015

2016

2017

No. (%)

No. (%)

No. (%)

No. (%)

No. (%)

Patients

7709

7914

7958

7804

7709

Deaths

165

151

138

114

124

Patients, excluded deaths

7544

7763

7820

7690

7585

Age

  ≤ 25

211 (3)

185 (2)

171 (2)

135 (2)

120 (2)

 26–35

1590 (21)

1570 (20)

1551 (20)

1403 (18)

1333 (18)

 36–45

2724 (36)

2730 (35)

2605 (33)

2508 (33)

3292 (32)

 46–55

2283 (30)

2449 (32)

2544 (33)

2540 (33)

2548 (34)

  ≥ 56

736 (10)

829 (11)

949 (12)

1104 (14)

1192 (16)

Mean (SD)

43 (10)

44 (10)

44 (10)

44 (10)

45 (10)

Gender

 Male

5221 (69)

5390 (69)

5430 (69)

5354 (70)

5245 (69)

 Female

2323 (31)

2373 (31)

2390 (31)

2336 (30)

2340 (31)

OAT opioidsa

 Methadone (included levomethadone)

3406 (45)

3264 (42)

3216 (41)

3066 (40)

2981 (39)

Buprenorphine (included combination with naloxone)

4138 (55)

4499 (58)

4604 (59)

4624 (60)

4604 (61)

Dispensed opioid analgesics

 - All

1430 (19)

1424 (18)

1400 (18)

1382 (18)

1359 (18)

- Strong opioid analgesic

542 (7)

518 (7)

490 (6)

534 (7)

526 (7)

 - Weak opioid analgesic

1089 (14)

1078 (14)

1066 (14)

1011 (13)

997 (13)

Dose of dispensed opioid analgesics (in OMEQ)

 - mean (mg/year)

18,538

17,399

8963

9361

10,723

 - mean (mg/day/year)

51

48

25

26

29

 - median (mg/year)

450

400

400

500

500

 - median (mg/day/year)

1

1

1

1

1

 - 25 percentile (mg/year)

86

75

90

100

100

 - 25 percentile (mg/day/year)

0

0

0

0

0

 - 75 percentile (mg/year)

4478

3321

2616

2891

3500

 - 75 percentile (mg/day/year)

12

9

7

8

10

Patients on palliative careb

737

Patients with chronic painc

2011

  1. No.: Number of patients; OAT Opioid agonist therapy, OMEQ Oral morphine equivalents, SD Standard deviation
  2. a The type of OAT opioid that was dispensed on the last dispensation per year
  3. b Patients who were dispensed drugs that were reimbursed due to palliative care in the study period
  4. c Patients who were dispensed a drug that was reimbursed due to chronic pain in the study period. Patients who were dispensed drugs that were reimbursed for palliative care and chronic pain were classified as ‘patients on palliative care’